Travere therapeutics, inc. investigation: levi & korsinsky investigates potential securities fraud by travere therapeutics, inc. (tvtx)

New york, ny / accesswire / october 9, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of travere therapeutics, inc. ("travere therapeutics, inc.") (nasdaq:tvtx) concerning possible violations of federal securities laws. travere issued a press release on september 26, 2024, "announc[ing] a voluntary pause of enrollment in the phase 3 harmony study evaluating pegtibatinase for the treatment of classical homocystinuria (hcu).
TVTX Ratings Summary
TVTX Quant Ranking